a month ago
TSHA
AnalystsWhitney IjemWhitney Ijem's Stock Forecasts
AnalystsWhitney Ijem
Sectors:
Industries:
Analyst Ranking
Top 5%
#233 out of 5267 analysts
Average Return
+27.92%
Win Rate
49%63 out of 128
Risk vs Reward
Poor
Good
Whitney Ijem's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcturus Therapeutics Holdings IncARCT | +606.98% | $12.03 | $85.05 | 2020-02-06 - 2021-02-05 | Strong Buy |
Palvella Therapeutics IncPVLA | +584.04% | $18.80 | $128.60 | 2025-02-25 - 2026-02-25 | Strong Buy |
Regulus Therapeutics IncRGLS | +482.48% | $1.37 | $7.98 | 2025-03-16 - 2025-04-30 | Strong Buy |
Palvella Therapeutics IncPVLA | +478.73% | $22.05 | $127.61 | 2025-05-15 - 2026-05-04 | Strong Buy |
Palvella Therapeutics IncPVLA | +346.35% | $26.97 | $120.38 | 2025-04-01 - 2026-04-01 | Strong Buy |
Whitney Ijem Analyst Color
Get additional color on Whitney Ijem's coverage of popular stocks
2 months ago
WVE
2 months ago
BMRN
3 months ago
ALNY
3 months ago
WVE
4 months ago
BMRN
5 months ago
PVLA
5 months ago
RYTM
5 months ago
WVE
5 months ago
GUTS
6 months ago
PVLA
6 months ago
RYTM
7 months ago
PVLA
9 months ago
PVLA
9 months ago
TSHA
9 months ago
ALNY
10 months ago
RYTM
a year ago
TSHA
a year ago
TSHA
a year ago
TNYA
a year ago
SRPT
a year ago
VERV
a year ago
RYTM
2 years ago
RARE
2 years ago
ARCT
Whitney Ijem's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vertex Pharmaceuticals IncVRTX | 11 | Hold | $437.00 | +1.66% | Maintains | 5 days ago |
Wave Life Sciences LtdWVE | 5 | Strong Buy | $43.00 | +475.64% | Maintains | 5 days ago |
Intellia Therapeutics IncNTLA | 8 | Strong Buy | $58.00 | +318.17% | Maintains | 7 days ago |
Pharming Group NvPHAR | 1 | Strong Buy | $37.00 | +125.75% | Initiates Coverage On | 25 days ago |
Taysha Gene Therapies IncTSHA | 12 | Strong Buy | $17.00 | +156.02% | Maintains | a month ago |
Neurogene IncNGNE | 2 | Strong Buy | $180.00 | +537.85% | Maintains | a month ago |
Fractyl Health IncGUTS | 3 | Strong Buy | $8.00 | +1,000.41% | Maintains | a month ago |
Ocugen IncOCGN | 1 | Strong Buy | $12.00 | +548.65% | Initiates Coverage On | 2 months ago |
Arcturus Therapeutics Holdings IncARCT | 6 | Strong Buy | $21.00 | +145.04% | Maintains | 2 months ago |
Passage Bio IncPASG | 8 | Strong Buy | $23.00 | +403.28% | Maintains | 2 months ago |
Rhythm Pharmaceuticals IncRYTM | 10 | Strong Buy | $140.00 | +63.59% | Maintains | 2 months ago |
Biomarin Pharmaceutical IncBMRN | 10 | Strong Buy | $104.00 | +87.52% | Maintains | 2 months ago |
Beam Therapeutics IncBEAM | 1 | Strong Buy | $74.00 | +146.01% | Initiates Coverage On | 2 months ago |
Ultragenyx Pharmaceutical IncRARE | 10 | Strong Buy | $79.00 | +218.42% | Maintains | 3 months ago |
Alnylam Pharmaceuticals IncALNY | 10 | Strong Buy | $429.00 | +44.00% | Maintains | 3 months ago |
Tenaya Therapeutics IncTNYA | 7 | Strong Buy | $5.00 | +532.91% | Maintains | 5 months ago |
Palvella Therapeutics IncPVLA | 8 | Strong Buy | $204.00 | +59.86% | Maintains | 5 months ago |
Generation Bio CoGBIO | 3 | Strong Buy | $10.00 | +87.27% | Maintains | 9 months ago |
Rocket Pharmaceuticals IncRCKT | 9 | Strong Buy | $10.00 | +177.01% | Maintains | 9 months ago |
Verve Therapeutics IncVERV | 6 | Hold | $13.00 | +16.80% | Downgrades | a year ago |
Regulus Therapeutics IncRGLS | 6 | Hold | $11.00 | N/A | Downgrades | a year ago |
Sarepta Therapeutics IncSRPT | 1 | Strong Buy | $150.00 | N/A | Maintains | a year ago |
Sigilon Therapeutics IncSGTX | 2 | Strong Buy | $30.00 | N/A | Maintains | 3 years ago |
Neubase Therapeutics IncNBSE | 1 | Strong Buy | $260.00 | N/A | Initiates Coverage On | 6 years ago |
Karyopharm Therapeutics IncKPTI | 4 | Strong Buy | $240.00 | N/A | Upgrades | 7 years ago |
Acceleron Pharma IncXLRN | 2 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.